$460 Million is the total value of Parkman Healthcare Partners LLC's 83 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGEN | Sell | SEAGEN INC | $14,800,557 | +40.7% | 73,100 | -10.7% | 3.22% | +14.9% |
| LLY | Sell | LILLY ELI & CO | $9,502,775 | -24.6% | 27,671 | -19.6% | 2.07% | -38.4% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $3,972,000 | -22.2% | 100,000 | -21.2% | 0.86% | -36.4% |
| DHR | Sell | DANAHER CORPORATION | $3,835,041 | -62.4% | 15,216 | -60.4% | 0.83% | -69.3% |
| ETNB | Sell | 89BIO INC | $3,761,140 | -11.2% | 246,956 | -25.8% | 0.82% | -27.5% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $2,295,658 | -50.0% | 47,608 | -48.2% | 0.50% | -59.2% |
| Sell | PROCEPT BIOROBOTICS CORP | $1,909,957 | -59.1% | 67,252 | -40.1% | 0.42% | -66.6% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $1,343,102 | -65.5% | 166,020 | -32.8% | 0.29% | -71.8% |
| Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -42,749 | -100.0% | -0.03% | – | |
| PSTV | Exit | PLUS THERAPEUTICS INC | $0 | – | -583,467 | -100.0% | -0.05% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -35,000 | -100.0% | -0.25% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -25,000 | -100.0% | -0.30% | – |
| OPNT | Exit | OPIANT PHARMACEUTICALS INC | $0 | – | -59,943 | -100.0% | -0.32% | – |
| Exit | SIGHT SCIENCES INC | $0 | – | -105,102 | -100.0% | -0.34% | – | |
| LNDC | Exit | LIFECORE BIOMEDICAL INC | $0 | – | -203,578 | -100.0% | -0.35% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.37% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -206,866 | -100.0% | -0.40% | – |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -226,867 | -100.0% | -0.75% | – |
| TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -55,351 | -100.0% | -0.91% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -54,579 | -100.0% | -1.08% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -35,314 | -100.0% | -1.22% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -157,862 | -100.0% | -1.22% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -1,203,484 | -100.0% | -1.87% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -27,742 | -100.0% | -3.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.